Fingerprint
Dive into the research topics of 'Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
Jeeyun Lee, Su Jin Lee, Jongtae Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung Mee Kim, In Gu Do, Sin Ho Jung, Dong Seok Yim, Won Ki Kang
Research output: Contribution to journal › Article › peer-review
31
Scopus
citations